Exposure of bovine chromaffin cells in primary culture to 5 ,.M reserpine or 25 ,uM forskolin results in an increase in enkephalin peptide levels within 24-48 hr; 25 j!M forskolin (or cholera toxin at 50 ,.g/ml) causes a 1.5-to 2-fold increase in enkephalin peptide levels, which is maximal after 48 hr of exposure and is totally blocked by addition of cycloheximide (0.5 ,Lg/ml). Reserpine (5 ,.M) elicits a 1.5-to 2-fold increase in enkephalin peptide levels within 24 hr, which is only partially blocked by cycloheximide. Chromatographic analysis of cellular extracts shows that forskolin increases levels of both [Metlenkephalin pentapeptide and high molecular weight enkephalin-containing peptides, while reserpine causes an increase in [Metlenkephalin pentapeptide and a concomitant Decrease in high molecular weight enkephalin-containing peptides, suggesting enhanced conversion of enkephalin precursor(s) to the mature polypeptide hormone. Measurement of preproenkephalin messenger RNA (mRNAe k) by RNA blot hybridization witli a cDNA probe for mRNAenk reveals that forskolin and cholera toxin cause a relatively rapid (<17 hr) 3-to 5-fold increase in mRNAenk, while exposure to reserpine elicits a gradual decrease in enkephalin mRNA (a 50%-80% decline) beginning within 24 hr and continuing over a 72-hr peritd. These results suggest that forskolin and reserpine differentially regulate enkephalin biosynthesis in cultured chromaffin cells, the former by increasing, presumably via a cAMP-dependent mechanism, cellular mRNA coding for preproenkephalin and the latter by a post-translational increase in proenkephalin processing.
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The parenchymal or chromaffin cells of the adrenal medulla have been long studied as a prototype of the biochemistry and cell biology of catecholamine biosynthesis and secretion in diverse neuroendocrine cell types and in neurons (1, 2) . The bovine adrenal medulla also contains high levels of enkephalin peptides and has been used as starting material both for the purification and sequencing of preproenkephalin peptides and for cloning and sequencing complementary DNA to preproenkephalin messenger RNA (mRNAenk) (3) (4) (5) (6) . In addition, primary cultures of bovine adrenomedullary cells have been used as a model system to examine enkephalin peptide co-release with catecholamines and the regulation of enkephalin biosynthesis by hormones and pharmacological agents (7) (8) (9) (10) (11) (12) . In this study, we examined whether the effects of two types of pharmacological agents known to increase enkephalin peptide levels in chromaffin cells (9, 10, 12) could be accounted for by increased enkephalin gene transcription, which would be reflected in increased cellular mRNAenk, or if post-transcriptional events such as mRNA translation or preproenkephalin processing might be regulat- (12) was measured by radioimmunoassay, using an enkephalin antiserum (RB-4) provided by Steve Sabol (National Heart, Lung, and Blood Institute, National Institutes of Health). 125I-labeled [Met]-enkephalin was used as a tracer and the antiserum was used at a final dilution of 1:60,000, in an assay buffer consisting of 50 mM NaPO4, pH 7.6/0.1% Triton X-100/Trasylol (0.5 TIU/ml; Sigma)/0.1% bovine serum albumin/10 mM EDTA/0.01% merthiolate. The specificity of the antiserum under these assay conditions was essentially as described (14, 15) .
Measurement of cAMP. cAMP was measured in 0.1 M HCl extracts of chromaffin cells using a cAMP radioimmunoassay kit supplied by New England Nuclear. The assay was carried out according to the manufacturer's instructions except that the final assay volume was 400 ,ul.
Chromatography. Hydrochloric acid (0.1 M) extracts of chromaffin cells were lyophilized, reconstituted in phosphate buffer, and chromatographed on a TSK-2000 SW molecular sieving column as described (15) . Column fractions were assayed for [Met] enkephalin immunoreactivity before and after digestion with trypsin and carboxypeptidase B (15 
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As shown in Table 1 (Table 1) . The majority of enkephalin peptides in chromaffin cells, as in the intact bovine adrenal medulla, are large polypeptides that contain enkephalin pentapeptide sequences flanked by pairs of basic amino acid residues (3, 4) . These peptides are biosynthetic precursors to [Met] enkephalin (3) .
Since the antibody used in this study (14, 15) metrically with an LKB soft laser scanner. Linearity of signal density with mRNAenk was established by scanning serial dilutions of forskolin-treated samples.
Quantitation of Total RNA. Duplicate agarose gels were stained in 20 mM 3-(N-morpholino)propanesulfonic acid/5 mM sodium acetate/1 mM EDTA, pH 7.0, containing ethidium bromide at 30 Ag/ml, followed by a 4-hr wash in the same buffer (Dale Graham, personal communication). Negative images of UV-transilluminated photographs of each stained gel were scanned densitometrically and the area of the peak over the 28S ribosomal band was compared to a dilution series of bovine adrenomedullary RNA of known concentration.
Preparation of cDNA Probes. Internal Pst I fragments of plasmids pbovenk and pHPE9 (see refs. 5 and 17) were prepared and 32P-labeled by nick-translation as described (12) . The two probes were used interchangeably with qualitatively similar results (data shown were obtained with the bovine probe).
Determination of Molecular Size of Bovine Chromaffin Cell mRNAenk. After hybridization with 32P-labeled pbovenk and autoradiography, the RNA blot containing chromaffin cell total nucleic acids was incubated for 10 min in a solution containing 0.5 M sodium acetate, pH 5.2/0.04% methylene blue, after pre-soaking in 5% acetic acid (18) tained after a 14-hr exposure, from which data plotted in figure were obtained. Subsequent sample blots were exposed to x-ray film for variable lengths of time and autoradiograms yielding signal densities between 2 and 35 (arbitrary units) were used to quantitate mRNAenk and carboxypeptidase B to liberate [Metlenkephalin from nonimmunoreactive species that contain it. The majority of cellular immunoreactive enkephalin measured by direct enkephalin radioimmunoassay co-elutes with authentic [Met]-enkephalin (i.e., Mr < 900) in extracts from untreated, reserpine-treated, and forskolin-treated cells (Fig. 1 A-C Treatment of column fractions with trypsin and carboxypeptidase B, however, reveals that the majority of enkephalin residues are contained in peptides of Mr > 6000 (Fig. 1 D-F) . In extracts of untreated cells, the ratio of high molecular weight (Mr, >6000) to low molecular weight (Mr, <900) enkephalin-containing peptides is -3.9:1 (Fig. 1D) . The chromatographic profile of reserpine-treated cell extracts after digestion of column fractions with trypsin/carboxypeptidase B reveals a ratio of high to low molecular weight enkephalin peptides of 1.5:1 (Fig. 1E ), indicating that reserpine causes an increase in [Met] enkephalin pentapeptide levels and a decrease in high molecular weight enkephalin-containing polypeptides. The ratio of high to low molecular weight enkephalin immunoreactivity after chromatography and trypsin/carboxypeptidase B digestion of forskolin-treated cell extracts, on the other hand, is -6.5:1 (Fig. 1F) 25 ,uM forskolin resulted in a 3-to 5-fold increase in mRNAenk after 17 hr of treatment ( Fig. 4 ; Table  2 ). At this time, 25 ,uM forskolin elicits a >9-fold increase in intracellular cAMP [untreated cells contained 297 ± 52 fmol of cAMP and forskolin-treated cells contained 2963 ± 306 fmol of cAMP per 300,000 cells after 24 hr of exposure (mean (12) . A similar increase in mRNAe k was observed with cholera toxin (50 ,ug/ml), which was maximal at 48 hr (Table 2) shown here is the first of three repeated experiments, which are R C summarized in Table 2 . Fig. 4 was repeated twice with the addition of a cholera toxin (CT; 50 ,ug/ml) treatment group, and the signal density of samples on each blot was corrected for total RNA in each sample and then percentage change relative to untreated samples at corresponding times. Values are the mean SEM of three determinations (wells). *P < 0.05; **P < 0.01; ***P < 0.001 compared to controls, using Student's two-tailed t test. See Table 1 for abbreviations and other details. pine at 5 uM did not significantly alter mRNAenk initially. By 48 hr, however, reserpine-treated cells contained <50% as much mRNAenk as untreated cells (Fig. 4; Table 2 ). It should be noted that none of the drug treatments altered total RNA levels (Fig. 3) .
When reserpine and forskolin were added in combination to chromaffin cell cultures, the increase in enkephalin peptide levels measured after 48 hr of exposure was approximately additive with respect to the increase elicited by either drug alone (Table 3 ). The effect of reserpine and forskolin in combination on cellular mRNAenk was likewise additive: a 2.9-fold increase in mRNAenk was measured after 48 hr of exposure to forskolin and reserpine together; forskolin alone elicited a 3.7-fold increase, and reserpine elicited a 1/2.3 decrease, in mRNAenk after 48 hr ( Fig. 5; Table 3 ).
DISCUSSION
At least two classes of pharmacological agents alter enkephalin peptide levels in adrenal medulla and cultured chromaffin cells (9, 10, 12) . One class of agents increases intracellular cAMP (forskolin, cholera toxin, isobutylmethylxanthine) or mimics the effects of increased intracellular cAMP (dibutyryl cAMP, 8-bromo-cAMP). A second class, which includes reserpine and tetrabenazine, inhibits vesicular catecholamine reuptake (19 Fig. 4 . C, untreated cells; R, 10 g±M reserpine; F, 50 ,uM forskolin; R+F, 10 ,uM reserpine/50 ,uM forskolin. Cells were harvested after 72 hr of exposure to the drugs. The data from three separate determinations (wells) for each condition are shown above and are summarized in Table 3. in [Met] enkephalin levels in chromaffin cell cultures in this study (Table 1) . While forskolin also increased levels of high molecular weight enkephalin-containing polypeptides, reserpine treatment actually decreased the ratio of high to low molecular weight enkephalin immunoreactivity present in chromaffin cells (Fig. 1 ). Reserpine elicited a much more rapid increase in [Met] enkephalin levels than did forskolin.
Furthermore, inhibition of protein synthesis completely abolished the induction of [Metlenkephalin caused by forskolin and cholera toxin, whereas the reserpine-induced increase in cellular [Met] enkephalin was only partially blocked by inhibiting protein synthesis. Forskolin and cholera toxin (as well as isobutylmethylxanthine, dibutyryl cAMP, and 8-bromo-cAMP; unpublished observations) caused a 3-to 5-fold increase in mRNAenk levels, which occurred prior to the increase in enkephalin peptide levels; reserpine was responsible for a gradual decrease in mRNAenk to 40o-50% of initial levels.
These data suggest that forskolin and reserpine alter enkephalin biosynthesis at different cellular loci. Since the induction of [Metlenkephalin by forskolin and cholera toxin requires new protein synthesis and is preceded by an increase in mRNA coding for preproenkephalin, it seems likely that these agents regulate enkephalin biosynthesis at the level of gene transcription (although an effect of the drugs on mRNA stabilization cannot be ruled out). Forskolin and cholera toxin both increase intracellular levels of cAMP (20) . Increased intracellular cAMP has already been suggested as an intermediary in the induction of tyrosine hydroxylase in adrenal medulla and cultured chromaffin cells (21, 22 [Met] enkephalin, and its activity is markedly pH dependent (26, 27) . Since reserpine inhibits vesicular catecholamine reuptake, which is linked to a transvesicular electrical and pH gradient (28, 29) , it may alter intravesicular pH or redox state and alter processing enzyme activity.
A second component of reserpine action is a gradual decrease in mRNAenk. Reserpine causes a 56% decrease in mRNAenk 48 hr after addition to chromaffin cells in culture, but only a 22% decrease in mRNAenk levels in forskolintreated cells. Thus, the pool of mRNAenk present in the resting cells appears to be more susceptible to the effect of reserpine than the pool of mRNAenk present in the cells after forskolin treatment. A possibility is that reserpine increases the translatability of a stored pool of mRNAenk in the chromaffin cell and, concomitantly, its susceptibility to degradation. This would account for the increase in [Met]enkephalin levels which is blocked by cycloheximide pretreatment as well as decreased mRNAenk levels after reserpine treatment.
Such a mechanism operates in the conversion of stored mRNA present in nontranslated RNase-insensitive ribonucleoprotein particles to translatable RNase-sensitive mRNA after fertilization of sea urchin and mouse eggs (30, 31) .
The precise biochemical mechanisms of enkephalin biosynthesis regulation by reserpine and forskolin remain to be determined. In any event, forskolin and reserpine represent pharmacological probes for at least two different modes of regulation of enkephalin biosynthesis in chromaffin cells, either or both of which may be part of the regulatory repertoire of neuroendocrine cells in vivo. We have recently observed, in fact, that nicotine, which acts at the cholinergic receptor mediating enkephalin release from the adrenal medulla in vivo, also causes an increase in enkephalin peptide biosynthesis and mRNAenk in cultured chromaffin cells, which is blocked by cycloheximide, an action like that of forskolin and cholera toxin (unpublished observations).
